ÂÜÀòÂÒÂ×

Jonas Ekblom is an experienced leader in the biopharmaceutical and gene therapy sectors, currently serving as the Chairman of the Board for CombiGene, Ziccum AB, and Oblique Therapeutics AB, alongside directorship roles at Moberg Pharma AB and Emplipharm AB. Between 2016 and 2023, Jonas held prominent positions as President and CEO of Promore Pharma AB and Chairman of EffRx Pharmaceuticals SA. Following the establishment of Pergamum AB, where Jonas acted as CEO and Board Director until its integration into Promore Pharma, the focus was on developing treatments for chronic wounds. Jonas possesses a strong academic background, including a Ph.D. in Experimental Neurology from Uppsala University and a Postdoctoral Fellowship in Molecular Pharmacology from the University of Southern California.